New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Hyderabad (Telangana) [India], September 24 (ANI): Vaccine Innovator, Bharat Biotech on Wednesday announced, a licensing agreement with Washington University School of Medicine (WUSM) in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for COVID-19.
Chandigarh (Punjab) [India], September 22 (ANI): Three Government Medical Colleges in Punjab will participate in the phase 3 trials of the COVAXIN being tested by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR) against COVID-19, said a statement from th
New Delhi [India], September 18 (ANI): There is a possibility of situation created by COVID-19 returning to normal by the middle of next year even if a vaccine is not developed by then, Dr Sanjay Rai, Professor in Community Medicine Department at AIIMS here, has said.
Rohtak (Haryana) [India], September 8 (ANI): Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine.
New Delhi [India], Aug 29 (ANI): Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial, Niti Aayog member Dr Vinod K Paul said on Saturday.
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Mumbai (Maharashtra) [India], July 4 (ANI): Maharashtra Health Minister Rajesh Tope is hopeful and positive about the indigenous COVID-19 vaccine after the Indian Council of Medical Research (ICMR) DG Balram Bhargava informed that the vaccine trial will begin by July 7 on Friday.
New Delhi [India], July 3 (ANI) The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method, so that results of
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
Hyderabad (Telangana) [India], June 30 (ANI): Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
New Delhi, May 9 [India], May 9 (ANI): The Indian Council of Medical Research (ICMR) on Saturday announced that it has partnered with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the National Institute o